CRMD RSI Chart
Last 7 days
0.7%
Last 30 days
13.9%
Last 90 days
70.1%
Trailing 12 Months
2.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 | 0 |
2022 | 27.2K | 39.9K | 52.7K | 65.4K |
2021 | 253.4K | 245.2K | 190.3K | 14.4K |
2020 | 193.6K | 174.8K | 208.3K | 239.2K |
2019 | 570.3K | 598.0K | 285.0K | 283.3K |
2018 | 313.0K | 184.4K | 495.8K | 429.8K |
2017 | 222.2K | 341.9K | 358.5K | 329.3K |
2016 | 220.3K | 116.8K | 125.3K | 224.1K |
2015 | 208.3K | 288.6K | 272.1K | 210.1K |
2014 | 0 | 0 | 0 | 189.3K |
2013 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 13, 2024 | todisco joseph | bought | 50,718 | 3.74 | 13,561 | chief executive officer |
Jan 12, 2024 | masson-hurlburt elizabeth | acquired | - | - | 50,000 | evp, head of clinical ops. |
Jan 12, 2024 | mistry erin | sold (taxes) | -15,229 | 3.47 | -4,389 | chief commercial officer |
Jan 12, 2024 | todisco joseph | acquired | - | - | 133,333 | chief executive officer |
Jan 12, 2024 | mistry erin | acquired | - | - | 50,000 | chief commercial officer |
Jan 12, 2024 | todisco joseph | sold (taxes) | -47,820 | 3.47 | -13,781 | chief executive officer |
Jan 12, 2024 | david matthew t | sold (taxes) | -18,099 | 3.47 | -5,216 | chief financial officer |
Jan 12, 2024 | masson-hurlburt elizabeth | sold (taxes) | -15,972 | 3.47 | -4,603 | evp, head of clinical ops. |
Jan 12, 2024 | david matthew t | acquired | - | - | 50,000 | chief financial officer |
Dec 15, 2023 | dunton alan w | bought | 9,900 | 3.3 | 3,000 | - |
Which funds bought or sold CRMD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 10, 2024 | WELLS FARGO & COMPANY/MN | added | 14.11 | 16,989 | 76,239 | -% |
May 10, 2024 | DIMENSIONAL FUND ADVISORS LP | unchanged | - | 10,368 | 91,588 | -% |
May 10, 2024 | PNC Financial Services Group, Inc. | added | 2,166 | 1,662 | 1,730 | -% |
May 10, 2024 | LPL Financial LLC | added | 140 | 140,208 | 222,176 | -% |
May 10, 2024 | OSAIC HOLDINGS, INC. | added | 53.49 | 7,443 | 17,628 | -% |
May 10, 2024 | BlackRock Inc. | reduced | -0.59 | 1,595,920 | 14,784,900 | -% |
May 10, 2024 | CIBC Private Wealth Group, LLC | unchanged | - | 17,220 | 175,140 | -% |
May 10, 2024 | CITIGROUP INC | added | 19.68 | 10,153 | 39,199 | -% |
May 10, 2024 | JPMORGAN CHASE & CO | reduced | -41.04 | -47,531 | 94,315 | -% |
May 10, 2024 | VANGUARD GROUP INC | added | 3.64 | 1,792,250 | 12,415,500 | -% |
Unveiling CorMedix Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to CorMedix Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 47.0B | 6.8B | -7.88 | 6.87 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 19.1B | 2.0B | -57.66 | 9.56 | ||||
BMRN | 15.5B | 2.5B | 75.52 | 6.28 | ||||
INCY | 12.0B | 3.8B | 16.12 | 3.19 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.83 | 48.09 | ||||
APLS | 5.2B | 524.1M | -12.37 | 9.85 | ||||
AXSM | 3.5B | 251.0M | -11.81 | 13.94 | ||||
ARWR | 3.1B | 240.7M | -6.52 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.5K | 3.09 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 411.3M | 28.39 | 4.49 | ||||
NVAX | 627.6M | 996.6M | -1.57 | 0.63 | ||||
CRBP | 467.4M | 881.7K | -13.85 | 481.06 | ||||
INO | 261.3M | 4.9M | -1.93 | 53.69 | ||||
IBIO | 6.6M | 2.1M | -0.24 | 2.14 |
CorMedix Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | - | - | - | - | 29,702 | 6,817 | 21,253 | 7,636 | 22,862 | 38,088 | 8,191 | 88,261 | 55,714 | 93,020 | 16,443 | 74,054 | 24,778 | 59,530 | 35,266 | 163,692 | 26,523 | 372,514 |
Cost Of Revenue | - | 818,539 | - | - | 406 | 1,469 | 332 | 1,527 | 48,007 | 25,166 | 14,426 | 61,339 | 57,232 | 79,913 | 19,184 | 48,517 | 46,125 | 79,026 | 21,128 | 226,955 | 22,114 | 312,434 |
Gross Profit | -Infinity% | -818,539 | - | - | 29,296 | 5,348 | 20,921 | 6,109 | 8,390 | 12,922 | -6,235 | 26,922 | -1,518 | 13,107 | -2,741 | 25,537 | -21,347 | -19,496 | 14,138 | -63,263 | 4,409 | 60,080 |
Operating Expenses | 1.4% | 15,885,697 | 15,668,744 | 11,017,179 | 8,418,524 | 6,967,282 | 8,261,366 | 7,038,470 | 7,788,310 | 8,577,841 | 5,875,993 | 7,237,440 | 6,083,122 | 6,616,862 | 8,917,868 | 5,637,285 | 5,354,477 | 5,152,019 | 5,551,494 | 4,859,918 | -2,133,822 | 10,301,533 |
S&GA Expenses | 12.5% | 15,048,252 | 13,379,855 | 7,609,677 | 5,575,302 | 4,628,014 | 5,051,895 | 4,750,883 | 4,553,091 | 3,836,613 | 3,355,790 | 4,601,108 | 3,788,693 | 3,691,507 | 3,232,576 | 3,165,168 | 2,677,470 | 2,631,027 | 2,571,587 | 1,984,922 | 2,213,440 | 2,012,439 |
R&D Expenses | -63.4% | 837,445 | 2,288,889 | 3,407,502 | 2,843,223 | 2,339,268 | 3,209,471 | 2,287,587 | 3,235,219 | 4,741,228 | 2,520,203 | 2,636,332 | 2,294,429 | 2,925,355 | 5,685,292 | 2,472,117 | 2,677,008 | 2,520,992 | 2,979,907 | 2,874,996 | -4,347,261 | 8,289,094 |
EBITDA Margin | -22.7% | -632 | -515 | -515 | -472 | -594 | -760 | -1,040 | -1,961 | -141 | -111 | -105 | -111 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 50.0% | 9,835 | 6,556 | 8,776 | 8,776 | 8,776 | 3,585 | 5,378 | 5,378 | 5,381 | - | 5,184 | 5,322 | 7,800 | 13,828 | 6,276 | 6,276 | 172,429 | 306,736 | 302,048 | - | - |
Income Taxes | -Infinity% | -1,394,770 | - | - | - | - | -585,617 | - | - | - | -1,250,186 | - | - | -3,138 | -5,169,395 | 6,276 | - | - | -5,060,778 | - | - | - |
Earnings Before Taxes | -Infinity% | -15,860,893 | - | -10,567,226 | -8,208,951 | -6,853,721 | -8,190,456 | - | -7,790,987 | -8,569,366 | -5,883,121 | - | -6,086,945 | -6,600,747 | -8,951,819 | - | -5,304,185 | -5,264,847 | -5,756,936 | - | 5,412,604 | -10,236,119 |
EBT Margin | -22.7% | -634 | -517 | -517 | -474 | -596 | -762 | -1,043 | -1,966 | -142 | -112 | -106 | -112 | - | - | - | - | - | - | - | - | - |
Net Income | 2.0% | -14,466,123 | -14,754,029 | -10,567,226 | -8,208,951 | -6,853,721 | -7,604,839 | -7,034,194 | -7,790,987 | -8,569,366 | -4,632,935 | -7,216,938 | -6,086,945 | -6,600,747 | -3,782,424 | -5,557,567 | -5,304,185 | -5,264,847 | -696,158 | -5,167,884 | 2,148,518 | -10,236,119 |
Net Income Margin | -8.4% | -768 | -708 | -508 | -454 | -556 | -776 | -1,032 | -1,958 | -139 | -100 | -93.46 | -92.08 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -57.3% | -17,371,600 | -11,041,625 | -10,408,652 | -6,283,594 | -6,071,854 | -5,471,978 | -6,748,666 | -6,498,121 | -6,281,407 | -3,097,132 | -6,703,892 | -6,010,571 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -17.1% | 68.00 | 82.00 | 91.00 | 57.00 | 59.00 | 62.00 | 62.00 | 68.00 | 65.00 | 69.00 | 75.00 | 81.00 | 84.00 | 49.00 | 40.00 | 24.00 | 27.00 | 29.00 | 34.00 | 28.00 | 27.00 |
Current Assets | -20.2% | 63.00 | 79.00 | 89.00 | 55.00 | 57.00 | 60.00 | 60.00 | 65.00 | 63.00 | 66.00 | 73.00 | 80.00 | 83.00 | 48.00 | 39.00 | 24.00 | 27.00 | 29.00 | 34.00 | 27.00 | 27.00 |
Cash Equivalents | -19.0% | 35.00 | 44.00 | 53.00 | 20.00 | 25.00 | 43.00 | 43.00 | 49.00 | 46.00 | 54.00 | 67.00 | 73.00 | 76.00 | 42.00 | 35.00 | 17.00 | 12.00 | 17.00 | 20.00 | 15.00 | 18.00 |
Inventory | 10.2% | 2.00 | 2.00 | - | - | - | - | 269* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net PPE | 2.1% | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | -16.0% | 10.00 | 12.00 | 8.00 | 8.00 | 5.00 | 7.00 | 6.00 | 6.00 | 5.00 | 6.00 | 6.00 | 4.00 | 4.00 | 5.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 11.00 | 11.00 |
Current Liabilities | -16.4% | 10.00 | 11.00 | 8.00 | 7.00 | 5.00 | 6.00 | 5.00 | 5.00 | 4.00 | 5.00 | 5.00 | 3.00 | 3.00 | 4.00 | 5.00 | 6.00 | 6.00 | 6.00 | 5.00 | 4.00 | 4.00 |
Shareholder's Equity | -17.3% | 58.00 | 70.00 | 83.00 | 49.00 | 54.00 | 55.00 | 56.00 | 62.00 | 60.00 | 63.00 | 69.00 | 77.00 | 80.00 | 44.00 | 34.00 | 0.00 | 22.00 | 24.00 | 29.00 | 16.00 | 17.00 |
Retained Earnings | -4.5% | -336 | -321 | -306 | -297 | -285 | -275 | -267 | -260 | -252 | -245 | -237 | -229 | -224 | -217 | -211 | -204 | -200 | -195 | -190 | -184 | -184 |
Additional Paid-In Capital | 0.6% | 394 | 392 | 390 | 346 | 340 | 330 | 323 | 322 | 312 | 308 | 307 | 306 | 305 | 262 | 246 | 223 | 222 | 219 | 219 | 201 | 201 |
Shares Outstanding | 0.0% | 55.00 | 55.00 | 55.00 | 46.00 | 44.00 | 43.00 | 41.00 | 40.00 | 38.00 | 38.00 | 38.00 | 37.00 | 36.00 | 34.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 180 | - | - | - | 164 | - | - | - | 208 | - | - | - | 208 | - | - | - | 209 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -61.1% | -17,310 | -10,745 | -8,697 | -8,572 | -10,393 | -6,154 | -5,995 | -5,462 | -6,744 | -5,869 | -5,503 | -3,091 | -6,690 | -5,933 | -7,312 | -754 | -7,966 | -3,884 | -3,964 | 164 | -7,367 |
Share Based Compensation | 100.8% | 2,444 | 1,217 | 1,003 | 1,057 | 2,216 | 874 | 984 | 1,074 | 1,138 | 1,253 | 1,048 | 1,010 | 1,732 | 516 | 611 | 696 | 677 | 453 | 571 | 606 | 809 |
Cashflow From Investing | 1396.3% | 8,945 | 598 | -586 | -2,385 | -14,686 | -1.86 | -114 | 594 | -4,187 | -7,129 | -1,271 | -208 | -526 | -1,847 | 3,243 | 5,045 | 985 | 296 | -477 | -3,874 | -7,964 |
Cashflow From Financing | -120.8% | -97.12 | 468 | 42,899 | 5,350 | 7,200 | 6,046 | 437 | 8,411 | 3,004 | - | - | 177 | 41,581 | 15,322 | 21,943 | - | 2,835 | -205 | 10,029 | 14.00 | 15,968 |
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenue: | ||
Net sales | $ 65,408 | |
Cost of sales | (3,734) | |
Gross profit | 61,674 | |
Operating Expenses: | ||
Research and development | (13,155,125) | (10,679,549) |
Selling, general and administrative | (35,802,663) | (20,006,093) |
Total operating expenses | (48,957,788) | (30,685,642) |
Loss From Operations | (48,957,788) | (30,623,968) |
Other Income (Expense): | ||
Interest income | 2,681,851 | 326,016 |
Foreign exchange transaction (loss) income | (28,994) | 37,145 |
Interest expense | (34,296) | (26,515) |
Total other income | 2,618,561 | 336,646 |
Net Loss Before Income Taxes | (46,339,227) | (30,287,322) |
Tax benefit | 585,617 | |
Net Loss | (46,339,227) | (29,701,705) |
Other Comprehensive Income (Loss): | ||
Unrealized gain from investments | 9,683 | 5,055 |
Foreign currency translation gain (loss) | 1,682 | (9,442) |
Total other comprehensive gain (loss) | 11,365 | (4,387) |
Comprehensive Loss | $ (46,327,862) | $ (29,706,092) |
Net Loss Per Common Share – Basic (in Dollars per share) | $ (0.91) | $ (0.74) |
Weighted Average Common Shares Outstanding – Basic (in Shares) | 50,902,931 | 40,274,273 |
Consolidated Balance Sheets - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 43,642,684 | $ 43,148,323 |
Restricted cash | 77,453 | 124,102 |
Short-term investments | 32,388,130 | 15,644,062 |
Inventories, net | 2,106,345 | |
Prepaid research and development expenses | 353,574 | 11,016 |
Other prepaid expenses and current assets | 882,214 | 623,672 |
Total current assets | 79,450,400 | 59,551,175 |
Property and equipment, net | 1,866,224 | 1,609,679 |
Restricted cash, long term | 103,055 | 102,320 |
Operating lease right-of-use assets | 640,278 | 775,085 |
TOTAL ASSETS | 82,059,957 | 62,038,259 |
Current liabilities | ||
Accounts payable | 4,279,679 | 2,202,149 |
Accrued expenses | 6,970,217 | 3,973,941 |
Operating lease liabilities, short-term | 150,619 | 134,801 |
Total current liabilities | 11,400,515 | 6,310,891 |
Operating lease liabilities, net of current portion | 517,013 | 667,632 |
TOTAL LIABILITIES | 11,917,528 | 6,978,523 |
COMMITMENTS AND CONTINGENCIES (Note 6) | ||
STOCKHOLDERS’ EQUITY | ||
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 181,622 shares issued and outstanding at December 31, 2023 and 2022 | 182 | 182 |
Common stock - $0.001 par value: 160,000,000 shares authorized at December 31, 2023 and 2022; 54,938,258 and 42,815,196 shares issued and outstanding at December 31, 2023 and 2022, respectively | 54,938 | 42,815 |
Accumulated other comprehensive gain | 94,108 | 82,743 |
Additional paid-in capital | 391,693,214 | 330,294,782 |
Accumulated deficit | (321,700,013) | (275,360,786) |
TOTAL STOCKHOLDERS’ EQUITY | 70,142,429 | 55,059,736 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 82,059,957 | $ 62,038,259 |